Global Ovarian Cancer Drugs Market 2019-2023
- Published: Feb 2019
- Pages: 126
- SKU: IRTNTR30795
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The ovarian cancer drugs market size will grow by USD 2.68 billion during 2019-2023. The report offers an analysis of the market based on type (epithelial, germ cell, stromal cell, and small cell ovarian cancer). The market research report further presents in-depth insights into the growth prospects of the market across geographic regions such as Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including AstraZeneca, Clovis Oncology, F. Hoffmann-La Roche, Spectrum Pharmaceuticals, and TESARO.
Below are some of the key findings from the ovarian cancer drugs market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.
Global ovarian cancer drugs industry overview
At present, there are more than 89 phase III clinical trials to evaluate drugs for the treatment of ovarian cancer. Most of these drugs are evaluating combination therapies of the existing drugs. Several companies are developing novel targeted therapies also. This leads to a strong pipeline for the treatment of ovarian cancer, which is one of the critical reasons that will drive the ovarian cancer drugs market’s growth. Researchers are evaluating novel targets such as sphingosine kinase 1 and deubiquitinating enzyme USP7 as recent studies have shown that ovarian cancer can become resistant to PARP inhibitors.
The growing number of research to develop effective combination therapies also assists in the development of a strong pipeline. This will drive the ovarian cancer drugs market to grow at a CAGR of over 22% during the forecast period. Researchers are developing effective combination therapies for disease management by researching the integrated roles of epigenetics, PD-L1 inhibitors, and angiogenesis inhibitors. Rational combination therapy and cell signaling ovarian cancer are also under study for the same purpose.
Top companies covered in the ovarian cancer drugs market research report
The ovarian cancer drugs market is moderately fragmented. Several companies are investing in the development of these drugs. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, the industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.
The report offers a complete analysis of various companies including:
- AstraZeneca
- Clovis Oncology
- F. Hoffmann-La Roche
- Spectrum Pharmaceuticals
- TESARO
Ovarian cancer drugs market segmentation based on geographic regions
- Asia
- Europe
- North America
- ROW
North America will hold the highest market share of the global ovarian cancer drugs market throughout the forecast period. The rising incidence of ovarian cancer, the availability of reimbursement schemes, and new drug approvals for the treatment of ovarian cancer are some of the primary reasons for the high growth of the ovarian cancer drugs market in the region.
Ovarian cancer drugs market segmentation based on the type
- Epithelial ovarian cancer
- Germ cell ovarian cancer
- Stromal cell ovarian cancer
- Small cell ovarian cancer
Epithelial ovarian cancer is the most common type of ovarian cancer. The epithelial ovarian cancer segment will account for the highest share of the ovarian cancer drugs market as it accounts for about 85%-90% of all ovarian neoplasms. Drugs used for epithelial ovarian cancer, both as part of the standard regimen and targeted therapy, are priced high, which contributes significantly to the growth of the segment.
Key highlights of the global ovarian cancer drugs market for the forecast period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the ovarian cancer drugs market during the next five years
- Precise estimation of the global ovarian cancer drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the industry across various geographies such as Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of companies
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Epithelial ovarian cancer - Market size and forecast 2018-2023
- Germ cell ovarian cancer - Market size and forecast 2018-2023
- Stromal cell ovarian cancer - Market size and forecast 2018-2023
- Small cell ovarian cancer - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Market trends
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AstraZeneca
- Clovis Oncology
- F. Hoffmann-La Roche
- Spectrum Pharmaceuticals
- TESARO
PART 14: APPENDIX
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
